{"gene":"NNT","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2012,"finding":"Loss-of-function mutations in NNT (nicotinamide nucleotide transhydrogenase) cause familial glucocorticoid deficiency; NNT knockdown in a human adrenocortical cell line impaired redox potential and increased reactive oxygen species (ROS) levels, and Nnt-deficient mice showed higher adrenocortical cell apoptosis and impaired glucocorticoid production, establishing NNT's role in ROS detoxification in adrenal steroidogenesis.","method":"Targeted exome sequencing of FGD patients; NNT knockdown in human adrenocortical cell line with ROS/redox assays; mouse Nnt loss-of-function model with histology and hormone measurements","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal human genetics + cell-line KD with redox readout + mouse KO with cellular phenotype, replicated across multiple labs subsequently","pmids":["22634753"],"is_preprint":false},{"year":2013,"finding":"NNT, as a mitochondrial NADH-to-NADPH reducing-equivalent transfer enzyme, coordinates reductive carboxylation and glucose catabolism in the TCA cycle: NNT knockdown inhibits glutamine contribution to the TCA cycle and reductive carboxylation by IDH1/IDH2, while activating glucose oxidation; NNT overexpression stimulates glutamine oxidation and reductive carboxylation and inhibits glucose catabolism, effects correlated with changes in NAD(P)H/NAD(P)+ ratios.","method":"Stable isotope tracer metabolic flux analysis; NNT knockdown and overexpression in SkMel5 melanoma and 786-O renal carcinoma cells; biochemical NADPH/NADP+ measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — isotope tracing plus gain- and loss-of-function in two independent cell lines with cofactor ratio measurements","pmids":["23504317"],"is_preprint":false},{"year":2014,"finding":"NNT links mitochondrial respiration to H2O2 detoxification in brain mitochondria via the thioredoxin/peroxiredoxin system: pharmacological inhibition of Nnt in isolated brain mitochondria reduced H2O2 consumption only in the presence of respiration substrates; Nnt inhibition or lentiviral knockdown in N27 dopaminergic cells decreased H2O2 catabolism, reduced NADPH, increased oxidized mitochondrial Prx, and sensitized cells to paraquat-induced death.","method":"Pharmacological inhibition of NNT in isolated brain and liver mitochondria; lentiviral Nnt knockdown in N27 dopaminergic cells; H2O2 consumption assays; NADPH/NADP+ measurements; Prx redox state assays; cell viability assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (isolated organelle assay, pharmacological inhibition, lentiviral KD, redox reporters) in single rigorous study","pmids":["24722990"],"is_preprint":false},{"year":2017,"finding":"In pancreatic β-cells, NNT operates primarily in reverse mode (consuming NADPH to support NADH) at non-stimulating glucose concentrations; glucose stimulation reduces NADPH consumption by NNT reverse mode, accounting for the glucose-induced rise in NADPH/NADP+ and decrease in mitochondrial glutathione oxidation. Loss of NNT in C57BL/6J islets did not alter Ca2+ influx or mitochondrial events but markedly reduced both phases of glucose-stimulated insulin secretion (GSIS) by altering Ca2+-induced exocytosis and its metabolic amplification.","method":"Comparison of NNT-null C57BL/6J vs. wild-type C57BL/6N islets; adenoviral NNT re-expression in J-islets; glutaredoxin 1-fused roGFP2 mitochondrial/cytosolic glutathione probes; biochemical NADPH/NADH measurements; dynamic insulin secretion assays; Ca2+ imaging","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genetically defined NNT-null vs. wild-type islets plus adenoviral rescue, multiple orthogonal reporters including live redox sensors","pmids":["28580284"],"is_preprint":false},{"year":2017,"finding":"NNT is essential for homeostasis of NADH and NADPH pools in cancer cells; NNT knockdown in SK-Hep1 cells decreased NAD+ and NADPH, increased α-ketoglutarate/succinate ratio leading to reduced HIF-1α levels and HIF-1α-regulated gene expression, reduced HDAC1 activity, increased p53 acetylation, increased dependence on oxidative phosphorylation, and impaired proliferation and tumorigenicity.","method":"NNT knockdown in SK-Hep1 cells; stable isotope tracer metabolic flux analysis; measurement of HIF-1α, HDAC1 activity, p53 acetylation; proliferation and tumorigenicity assays","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isotope tracing plus multiple pathway readouts in single lab, single cell line","pmids":["28478381"],"is_preprint":false},{"year":2017,"finding":"Transcriptomic profiling of adrenals from Nnt wild-type (C57BL/6N), Nnt-null (C57BL/6J), and BAC-transgenic Nnt-overexpressing mice showed that both under- and overexpression of NNT reduces adrenal steroidogenic output, correlating with decreased expression of mitochondrial antioxidant enzymes (Prdx3, Txnrd2) and the steroidogenic enzyme Cyp11a1, establishing NNT as a central regulator of adrenal redox homeostasis and steroidogenesis.","method":"RNA-seq on adrenals from three isogenic mouse models; corticosterone measurements; pathway enrichment analysis","journal":"The Journal of endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — three genetic models with transcriptomic and hormone output, single lab","pmids":["29046340"],"is_preprint":false},{"year":2012,"finding":"NNT regulates macrophage inflammatory responses: NNT overexpression in a macrophage cell line decreased ROS and nitric oxide upon LPS activation, impaired MAPK signaling pathway activation, reduced proinflammatory cytokine secretion, and impaired clearance of intracellular bacteria; conversely, C57BL/6J mice lacking functional Nnt showed greater macrophage ROS generation and stronger inflammatory response to Streptococcus pneumoniae infection.","method":"NNT overexpression in macrophage cell line; ROS and NO measurements; MAPK activation assays; cytokine secretion assays; intracellular bacterial clearance; in vivo infection model with Nnt-null C57BL/6J mice","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function in vitro plus in vivo Nnt-null mouse infection model, multiple orthogonal readouts, single lab","pmids":["22593545"],"is_preprint":false},{"year":2020,"finding":"NNT controls cellular redox state and skin pigmentation via a UVB- and MITF-independent mechanism: NNT inhibition causes redox changes that increase tyrosinase protein levels (by reducing tyrosinase degradation), promote melanosome maturation, and elevate eumelanin/pigmentation; topical NNT inhibitors darkened human skin ex vivo, and mice with decreased NNT function and zebrafish with genetic NNT modification displayed increased melanocytic pigmentation.","method":"Small-molecule NNT inhibitor topical application on human skin; NNT mouse models; CRISPR genetic modification of NNT in zebrafish; tyrosinase stability assays; melanosome maturation analysis; eumelanin quantification","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal model systems (human skin, mouse in vivo, zebrafish genetic), mechanistic link to tyrosinase degradation established","pmids":["34233163"],"is_preprint":false},{"year":2015,"finding":"Loss-of-function mutations in NNT are associated with left ventricular noncompaction (LVNC); suppression of nnt in zebrafish caused early ventricular malformation and contractility defects likely driven by altered cardiomyocyte proliferation; in vivo complementation with mutant human NNT failed to rescue nnt morpholino-induced heart dysfunction, indicating haploinsufficiency.","method":"Whole exome sequencing; zebrafish nnt morpholino knockdown with cardiac phenotyping; in vivo complementation with human NNT constructs","journal":"Circulation. Cardiovascular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — zebrafish in vivo model with complementation assay, single lab","pmids":["26025024"],"is_preprint":false},{"year":2020,"finding":"NNT critically regulates mitochondrial redox balance and endothelial function in response to angiotensin II: NNT knockdown in human aortic endothelial cells elevated mitochondrial ROS, impaired glutathione peroxidase and reductase activities, reduced NADPH/NADP+ ratio, disrupted mitochondrial membrane potential, impaired ATP production, and augmented eNOS phosphorylation at Ser1177 without increasing eNOS activity or NO production.","method":"NNT shRNA knockdown in human aortic endothelial cells; mitochondrial ROS measurement; glutathione enzyme activity assays; NADPH/NADP+ ratio; mitochondrial membrane potential; ATP production; eNOS phosphorylation and activity assays","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical readouts in human primary cells, single lab","pmids":["32763515"],"is_preprint":false},{"year":2023,"finding":"IL-1β stimulation causes acetylation of NNT at lysine K1042 (NNT K1042ac) via PCAF (p300/CBP-associated factor), which translocates to mitochondria upon IL-1β stimulation; K1042 acetylation enhances NNT enzymatic activity by increasing NNT's binding affinity for NADP+, boosting NADPH production, which sustains iron-sulfur cluster maintenance and protects tumor cells from ferroptosis and immune evasion.","method":"Co-IP and mitochondrial fractionation for PCAF translocation; acetylation site mapping; NADP+ binding affinity assays; site-directed mutagenesis of K1042; iron-sulfur cluster assays; ferroptosis assays; PD-1 blockade combination studies","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — post-translational modification identified with writer (PCAF), mutagenesis of modification site, enzymatic activity assay, multiple functional readouts","pmids":["37244254"],"is_preprint":false},{"year":2016,"finding":"A 3D structural model of human NNT based on bacterial transhydrogenase crystal structures identified key functional residues including the NAD binding site, the proton canal, and the dimerization interface; the flexible linker between domains II and III and a salt bridge between Arg882 and Asp830 are critical for domain III conformational changes associated with NNT's functional cycle; disease-causing FGD and LVNC missense variants map to these functionally critical regions.","method":"Homology modeling using bacterial transhydrogenase experimental structures; sequence-structure analysis; mapping of disease variants onto structural model","journal":"Human mutation","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational structural model only, no direct experimental structural validation","pmids":["27459240"],"is_preprint":false},{"year":2021,"finding":"NNT expression is transcriptionally regulated by MITF (microphthalmia-associated transcription factor) through direct binding to canonical E-BOX sequences proximal to the NNT promoter; MITF-driven NNT expression contributes to a global antioxidant program reducing cytosolic and mitochondrial ROS in melanoma cells.","method":"ChIP for MITF binding to NNT promoter E-BOX; ROS measurements in MITF-manipulated melanoma cells; NNT functional assays; zebrafish melanoma model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct transcription factor binding plus functional ROS readouts, peer-reviewed replication of preprint","pmids":["39277608"],"is_preprint":false},{"year":2021,"finding":"In skeletal muscle mitochondria (SMM), NNT supplies NADPH capable of supporting up to 600 pmol/mg/min of H2O2 removal; however, NNT-null (Nnt-/-) SMM maintained H2O2 removal at wild-type levels due to compensatory ~70% elevation in total activities of concurrent NADP+-reducing enzymes (IDH2, malic enzymes, glutamate dehydrogenase).","method":"Comparison of SMM from Nnt+/+ and Nnt-/- mice; H2O2 removal assays in intact and detergent-solubilized mitochondria; enzymatic activity assays for IDH2, malic enzymes, glutamate dehydrogenase; oxygen consumption measurements","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetically defined mouse model with multiple in vitro organelle assays, single lab","pmids":["34043997"],"is_preprint":false},{"year":2021,"finding":"NNT activity direction is determined by cellular redox state: in cystic fibrosis (CF) cells, NNT protein is elevated ~70% but NNT activity is ~30% lower than wild-type; the oxidized cellular redox state combined with low mitochondrial membrane potential drives NNT to operate in reverse mode (consuming NADPH to produce NADH), reducing its antioxidant function.","method":"Spectrophotometric NNT activity assays; western blotting for NNT protein; NADPH and NADH level measurements; mitochondrial ROS quantification; mitochondrial membrane potential measurements in CF vs. wild-type cells","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays in defined disease vs. control cells, single lab","pmids":["33478087"],"is_preprint":false},{"year":2011,"finding":"Human NNT was functionally expressed in Saccharomyces cerevisiae for the first time; mitochondria isolated from NNT-expressing yeast showed six-fold higher transhydrogenase activity than wild-type yeast mitochondria and partially uncoupled respiration, confirming NNT acts as a redox-driven proton pump; a fluorimetric assay for NNT activity in permeabilized yeast was developed and validated for pharmacological compound screening.","method":"Heterologous expression of human NNT cDNA in yeast; transhydrogenase activity assay in isolated yeast mitochondria; respiratory measurements; fluorimetric assay development and pharmacological compound library screen","journal":"Journal of biomolecular screening","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — reconstitution of human NNT in yeast with enzymatic activity confirmation, single study, single lab","pmids":["21602486"],"is_preprint":false},{"year":2022,"finding":"NNT is silenced by DNA hypermethylation in cisplatin-resistant NSCLC cells; NNT overexpression reduced cisplatin resistance primarily by inhibiting protective autophagy through decreasing NAD+ levels and thereby inactivating SIRT1 (not through direct NADPH/ROS effects); targeted demethylation of the NNT CpG island via CRISPR/dCas9-Tet1 restored NNT expression and reduced autophagy and cisplatin resistance.","method":"DNA methylation analysis; NNT overexpression in A549/DDP cells; autophagy assays; NAD+ level measurements; SIRT1 activity assays; NAD+ precursor rescue experiments; CRISPR/dCas9-Tet1 targeted demethylation","journal":"Archives of toxicology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway (NNT→NAD+→SIRT1→autophagy) defined with multiple orthogonal methods and CRISPR epigenetic rescue, single lab","pmids":["36336710"],"is_preprint":false},{"year":2023,"finding":"USP47 (ubiquitin-specific protease 47) regulates NNT protein stability through direct deubiquitination: proteomic analysis of Usp47-/- mouse skin showed NNT downregulation; NNT knockdown in irradiated HaCaT cells elevated mitochondrial ROS and mitochondrial membrane potential and impaired energy production, establishing NNT as a downstream effector of USP47 in cutaneous oxidative stress responses.","method":"Usp47-/- mouse skin models (radiation and imiquimod); proteomic analysis; NNT knockdown in HaCaT cells; mitochondrial ROS assays; mitochondrial membrane potential assays; ATP production measurements","journal":"Toxicology and applied pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro complementary models identifying USP47 as NNT-regulatory deubiquitinase, single lab","pmids":["37924851"],"is_preprint":false},{"year":2025,"finding":"PARP14 positively regulates NNT expression in microglia; loss of NNT caused ROS accumulation and microglial inflammation, which was suppressed by NNT overexpression or by the ROS inhibitor N-Acetylcysteine; PARP14-mediated NNT upregulation suppresses microglial activation and alleviates depressive-like behavior in CUS mice.","method":"PARP14 knockdown/overexpression in hippocampus of CUS mice; microglial-targeted PARP14 overexpression; NNT overexpression rescue; ROS measurements; NAC treatment; depressive behavioral testing","journal":"Brain, behavior, and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (PARP14→NNT→ROS→inflammation) established with in vivo rescue and ROS inhibitor confirmation, single lab","pmids":["39978699"],"is_preprint":false},{"year":2025,"finding":"NNT promotes diastolic dysfunction in cardiometabolic HFpEF: isogenic Nnt+/+ mice subjected to HFD+L-NAME developed significantly worse diastolic dysfunction (elevated E/e', E/A, diastolic stiffness, myocardial fibrosis) compared to Nnt-/- mice; Nnt+/+ mice showed 40% reduction in NAD+ and 38.8% reduction in GSH:GSSG ratio after HFD+L-NAME; single-nucleus ligand-receptor analysis implicated Fgf1 as a putative NNT-dependent mediator of cardiomyocyte-to-fibroblast signaling in fibrosis.","method":"Isogenic Nnt+/+ vs. Nnt-/- mouse model in C57BL/6N background; HFD+L-NAME 2-hit HFpEF model; echocardiography; liquid chromatography-mass spectrometry for NAD+/glutathione; histology for fibrosis; single-nucleus transcriptomics and ligand-receptor analysis","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic genetic model with multiple cardiac and metabolic readouts, single lab","pmids":["40340422"],"is_preprint":false},{"year":2024,"finding":"Pathogenic NNT variants in patients with primary adrenal insufficiency result in complete absence of NAD(P)+ transhydrogenase activity (<4% of controls) in peripheral blood mononuclear cells, independent of the specific variant; heterozygous carrier parents have approximately half normal NNT activity; pathogenic NNT variants do not impair mitochondrial bioenergetic function (oxygen consumption) in PBMCs.","method":"Reverse reaction NNT enzymatic assay in digitonin-permeabilized PBMCs from patients, carriers, and controls; western blotting for NNT protein; RT-qPCR; mitochondrial oxygen consumption; validated in mouse NNT-null PBMC samples","journal":"European journal of endocrinology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — direct enzymatic activity assay in patient-derived primary cells validated against mouse model, single lab","pmids":["38261461"],"is_preprint":false},{"year":2025,"finding":"A gain-of-function missense variant in NNT (c.2063T>G, p.Leu688Trp) causes premature diffuse familial sebaceous hyperplasia by enhancing NNT antioxidant capacity: patient-derived keratinocytes and NNT-knockdown sebocytes overexpressing mutant NNT showed elevated NADPH/NADP+ ratio, increased glutathione, decreased ROS, and decreased susceptibility to ferroptosis compared to wild-type NNT.","method":"Whole-exome sequencing; functional assays in patient-derived keratinocytes; NNT-knockdown SZ95 sebocytes with mutant NNT overexpression; NADPH/NADP+ quantification; glutathione assays; ROS measurements; C11-BODIPY ferroptosis assays; flow cytometry; electron microscopy of mitochondria","journal":"The British journal of dermatology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — gain-of-function variant characterized with enzymatic and redox readouts in patient-derived and engineered cells, single lab","pmids":["40709434"],"is_preprint":false},{"year":2024,"finding":"NNT deficiency causes age-dependent skeletal muscle bioenergetic impairment: Nnt-/- mice showed decreased respiratory rates in soleus and vastus lateralis muscles at middle and older ages (but not in young mice), increased centralized nuclei in older soleus fibers, and worsened wire-hang performance; soleus, the muscle with highest NNT expression, was most affected by NNT loss during aging.","method":"Nnt-/- vs. Nnt+/+ mice across three ages; wire-hang locomotor performance test; mitochondrial respiration in fiber bundles from multiple muscles; histology with centralized nuclei scoring; NNT expression profiling across muscles","journal":"Experimental gerontology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic genetic model with longitudinal functional and organelle-level measurements, single lab","pmids":["38795789"],"is_preprint":false},{"year":2019,"finding":"Saturated fatty acid palmitate decreases NNT expression in PBMCs, reducing NADPH and glutathione and increasing ROS and Th17 proinflammatory cytokines; genetic inhibition of NNT recapitulated these effects; obese subjects had lower NNT and glutathione expression compared to lean subjects, identifying NNT as a palmitate-regulated rheostat of redox balance in immune cells.","method":"Palmitate treatment of PBMCs from lean subjects; genetic NNT inhibition in PBMCs; NADPH, glutathione, ROS measurements; cytokine assays; comparison with obese vs. lean subjects","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic NNT manipulation with multiple redox and inflammatory readouts, single lab","pmids":["30823587"],"is_preprint":false},{"year":2021,"finding":"NNT downregulation in clear cell renal cell carcinoma is mediated by HIF2α, which enhances miR-455-5p expression via HIF2α-response elements in the miR-455-5p promoter; miR-455-5p in turn suppresses NNT expression by binding to its 3' UTR. Reduced NNT leads to decreased lipid browning-mediated tumor cell 'slimming', promoting tumor progression.","method":"HIF2α knockdown followed by NNT expression analysis; ChIP for HIF2α binding to miR-455-5p promoter; luciferase reporter assay confirming miR-455-5p targeting of NNT 3' UTR; cell line and animal models","journal":"Clinical and translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus luciferase validation of regulatory axis, single lab","pmids":["33463050"],"is_preprint":false},{"year":2025,"finding":"NNT deficiency in aged mice causes cardiac hypertrophy and moderately reduced ejection fraction/fractional shortening, associated with increased mitochondrial H2O2 release under specific conditions; mitochondrial bioenergetic parameters and Ca2+ retention capacity were largely unaffected by Nnt genotype at all ages, indicating NNT protects aging heart through redox balance maintenance without being essential for bioenergetics.","method":"Nnt-/- vs. Nnt+/+ mice assessed at 5, 12, and 23 months; echocardiography; mitochondrial H2O2 production assays; mitochondrial respiration; Ca2+ retention capacity assays; cardiac histology","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic longitudinal genetic model with multiple cardiac and mitochondrial readouts, single lab","pmids":["41274037"],"is_preprint":false}],"current_model":"NNT (nicotinamide nucleotide transhydrogenase) is an inner mitochondrial membrane proton-translocating enzyme that couples the proton gradient to transfer reducing equivalents from NADH to NADPH (forward mode), thereby maintaining the mitochondrial NADPH pool for ROS detoxification via the thioredoxin/peroxiredoxin and glutathione systems; it can also operate in reverse (consuming NADPH to support NADH) depending on cellular redox state, and its activity is post-translationally enhanced by IL-1β-induced PCAF-mediated acetylation at K1042; NNT is a critical regulator of adrenal steroidogenesis, pancreatic β-cell insulin secretion, macrophage inflammatory responses, skin pigmentation via tyrosinase stability, and cardiomyocyte redox homeostasis, with loss-of-function mutations causing familial glucocorticoid deficiency in humans."},"narrative":{"mechanistic_narrative":"NNT is an inner mitochondrial membrane, redox-driven proton pump that couples the respiratory proton gradient to transfer of reducing equivalents from NADH to NADP+, maintaining the mitochondrial NADPH pool that feeds the thioredoxin/peroxiredoxin and glutathione antioxidant systems [PMID:24722990, PMID:21602486]. Heterologous expression of human NNT in yeast confirmed it functions as a transhydrogenase that partially uncouples respiration, and patient-derived cells from primary adrenal insufficiency show that pathogenic variants abolish NAD(P)+ transhydrogenase activity while leaving mitochondrial bioenergetics intact [PMID:21602486, PMID:38261461]. The direction of NNT catalysis is set by cellular redox state and membrane potential: in pancreatic β-cells and in oxidized, low-potential conditions NNT runs in reverse, consuming NADPH to generate NADH [PMID:28580284, PMID:33478087]. By controlling NADPH and NAD(H) pools, NNT governs reductive carboxylation and the balance between glutamine and glucose catabolism in the TCA cycle [PMID:23504317]. NNT activity is acutely enhanced by IL-1β-triggered, PCAF-mediated acetylation at K1042, which raises NADP+ binding affinity to boost NADPH output, sustaining iron-sulfur cluster maintenance and protecting tumor cells from ferroptosis [PMID:37244254]. Through this redox/ROS-buffering function NNT is a central regulator of adrenal steroidogenesis, where both loss and overexpression reduce steroidogenic output [PMID:22634753, PMID:29046340]; of pancreatic β-cell glucose-stimulated insulin secretion [PMID:28580284]; of macrophage and microglial inflammatory responses [PMID:22593545, PMID:39978699]; of skin pigmentation via redox-dependent tyrosinase stability [PMID:34233163]; and of cardiomyocyte and endothelial redox homeostasis [PMID:32763515, PMID:41274037]. Loss-of-function NNT mutations cause familial glucocorticoid deficiency [PMID:22634753], and a gain-of-function variant causes familial sebaceous hyperplasia by enhancing antioxidant capacity [PMID:40709434]. NNT expression is itself regulated transcriptionally by MITF and post-translationally by the deubiquitinase USP47 [PMID:39277608, PMID:37924851].","teleology":[{"year":2011,"claim":"Establishing whether human NNT is itself a redox-driven proton-pumping transhydrogenase required reconstituting the isolated enzyme, which heterologous yeast expression provided along with a screenable activity assay.","evidence":"Heterologous expression of human NNT in S. cerevisiae with transhydrogenase and respiratory assays and a fluorimetric screen","pmids":["21602486"],"confidence":"Medium","gaps":["No high-resolution experimental structure of human NNT","Directionality control in intact mammalian cells not addressed"]},{"year":2012,"claim":"Linking NNT to human disease defined its physiological role: loss-of-function mutations cause familial glucocorticoid deficiency through failure of ROS detoxification in steroidogenic adrenal cells.","evidence":"Exome sequencing of FGD patients, adrenocortical cell-line knockdown with redox/ROS assays, and Nnt-deficient mice","pmids":["22634753"],"confidence":"High","gaps":["Molecular link between redox imbalance and the steroidogenic defect not fully resolved","Tissue-selectivity of the adrenal phenotype unexplained"]},{"year":2012,"claim":"Whether NNT shapes innate immunity was tested by manipulating it in macrophages, showing NNT dampens ROS-driven inflammatory signaling and bacterial responses.","evidence":"NNT overexpression in macrophages plus Nnt-null mouse infection model with ROS, MAPK, and cytokine readouts","pmids":["22593545"],"confidence":"Medium","gaps":["Direct molecular target downstream of redox change not identified","Single lab"]},{"year":2013,"claim":"How NNT integrates into central carbon metabolism was clarified: by setting NAD(P)H/NAD(P)+ ratios it coordinates reductive carboxylation versus glucose oxidation in the TCA cycle.","evidence":"Stable-isotope flux analysis with NNT loss- and gain-of-function in melanoma and renal carcinoma cells","pmids":["23504317"],"confidence":"High","gaps":["In vivo relevance of the flux shifts not established","Does not address directional switching of NNT"]},{"year":2014,"claim":"The mechanistic basis for NNT's antioxidant function was tied to respiration-dependent NADPH supply feeding the thioredoxin/peroxiredoxin system for H2O2 removal.","evidence":"Pharmacological inhibition and knockdown in brain mitochondria and dopaminergic cells with H2O2 consumption and Prx redox readouts","pmids":["24722990"],"confidence":"High","gaps":["Relative contribution versus other NADPH sources not quantified here","In vivo neuronal consequence not tested"]},{"year":2017,"claim":"Resolving NNT's catalytic direction in vivo, β-cell studies showed it runs in reverse at low glucose and that this redox switching shapes glucose-stimulated insulin secretion.","evidence":"NNT-null vs wild-type islets with adenoviral rescue, live glutathione redox probes, and dynamic insulin secretion assays","pmids":["28580284"],"confidence":"High","gaps":["Molecular sensor coupling NNT directionality to glucose not defined","Exocytosis amplification mechanism incompletely mapped"]},{"year":2017,"claim":"NNT's role in cancer cell fitness was probed, linking its control of NAD+/NADPH to HIF-1α stability, HDAC1/p53 acetylation, and proliferation.","evidence":"NNT knockdown in SK-Hep1 cells with flux analysis and multiple pathway readouts","pmids":["28478381"],"confidence":"Medium","gaps":["Single cell line","Causal chain from cofactor change to each downstream node not isolated"]},{"year":2017,"claim":"Adrenal transcriptomics across three isogenic genotypes established NNT as a dose-sensitive regulator, since both under- and overexpression depress steroidogenesis and antioxidant gene expression.","evidence":"RNA-seq and corticosterone measurement in Nnt-null, wild-type, and overexpressing mice","pmids":["29046340"],"confidence":"Medium","gaps":["Mechanism of overexpression toxicity not defined","Single lab"]},{"year":2020,"claim":"NNT was shown to control skin pigmentation through a UVB/MITF-independent redox mechanism that stabilizes tyrosinase and promotes melanosome maturation.","evidence":"Small-molecule NNT inhibition on human skin ex vivo plus mouse and zebrafish models with tyrosinase stability and eumelanin assays","pmids":["34233163"],"confidence":"High","gaps":["Redox species that controls tyrosinase degradation not pinpointed","Degradation machinery involved not identified"]},{"year":2020,"claim":"Endothelial studies extended NNT's antioxidant role to vascular biology, showing its loss elevates mitochondrial ROS and disrupts bioenergetics in response to angiotensin II.","evidence":"NNT shRNA knockdown in human aortic endothelial cells with redox, membrane potential, ATP, and eNOS assays","pmids":["32763515"],"confidence":"Medium","gaps":["eNOS Ser1177 phosphorylation increase without NO change unexplained","Single lab"]},{"year":2023,"claim":"A regulatory layer was uncovered: IL-1β-driven PCAF acetylation of NNT at K1042 enhances NADP+ binding and NADPH output, protecting tumor cells from ferroptosis and immune attack.","evidence":"Co-IP/fractionation for PCAF, acetylation site mapping, K1042 mutagenesis, NADP+ binding and ferroptosis assays, PD-1 blockade studies","pmids":["37244254"],"confidence":"High","gaps":["Deacetylase counteracting K1042ac not identified","Generality beyond the tumor context tested unclear"]},{"year":2023,"claim":"NNT protein stability was shown to be set by deubiquitination, identifying USP47 as a regulator upstream of NNT in cutaneous oxidative stress.","evidence":"Usp47-/- mouse skin proteomics plus NNT knockdown in HaCaT cells with mitochondrial ROS and energy assays","pmids":["37924851"],"confidence":"Medium","gaps":["Direct USP47–NNT interaction and ubiquitin sites not mapped","Single lab"]},{"year":2024,"claim":"Direct enzymatic assays in patient cells established that pathogenic NNT variants abolish transhydrogenase activity without impairing mitochondrial bioenergetics, refining the disease mechanism.","evidence":"Reverse-reaction NNT assay in permeabilized PBMCs from patients, carriers, and controls with oxygen consumption measurements","pmids":["38261461"],"confidence":"Medium","gaps":["Does not explain tissue specificity of adrenal failure","Bioenergetic readout limited to PBMCs"]},{"year":2025,"claim":"A gain-of-function NNT variant defined the opposite end of the dose-response, causing sebaceous hyperplasia by enhancing antioxidant capacity and ferroptosis resistance.","evidence":"Exome sequencing and functional assays in patient keratinocytes and mutant-NNT sebocytes with NADPH, glutathione, ROS, and ferroptosis readouts","pmids":["40709434"],"confidence":"Medium","gaps":["Structural basis of the activating effect not resolved","Single lab"]},{"year":2025,"claim":"Longitudinal cardiac and muscle models clarified that NNT protects aging tissue through redox balance rather than core bioenergetics, with effects on hypertrophy, diastolic dysfunction, and muscle performance.","evidence":"Isogenic Nnt-/- vs Nnt+/+ mice across ages with echocardiography, HFpEF modeling, mitochondrial H2O2 and respiration assays, and single-nucleus transcriptomics","pmids":["41274037","40340422","38795789"],"confidence":"Medium","gaps":["Fgf1 as NNT-dependent cardiomyocyte-fibroblast mediator only correlative","Genetic-background confounds (C57BL/6J Nnt allele) require care in interpretation"]},{"year":null,"claim":"How NNT directionality is dynamically sensed and switched within intact mammalian tissues, and what governs its dose-sensitive, context-specific phenotypes, remains incompletely defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No experimental high-resolution structure of human NNT","Deacetylase opposing K1042ac unidentified","Mechanistic basis of dose-sensitivity (loss vs overexpression both harmful) unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[2,13,15,20]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[15]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[10]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,3,10,15]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,2,9,25]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[10,21]}],"complexes":[],"partners":["PCAF","USP47"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13423","full_name":"NAD(P) transhydrogenase, mitochondrial","aliases":["Nicotinamide nucleotide transhydrogenase","Pyridine nucleotide transhydrogenase"],"length_aa":1086,"mass_kda":113.9,"function":"The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane (By similarity). May play a role in reactive oxygen species (ROS) detoxification in the adrenal gland (PubMed:22634753)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/Q13423/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NNT","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MYH9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NNT","total_profiled":1310},"omim":[{"mim_id":"614736","title":"GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4","url":"https://www.omim.org/entry/614736"},{"mim_id":"612572","title":"RETINITIS PIGMENTOSA 46; RP46","url":"https://www.omim.org/entry/612572"},{"mim_id":"612147","title":"MYOSIN LIGHT CHAIN KINASE 3; MYLK3","url":"https://www.omim.org/entry/612147"},{"mim_id":"607878","title":"NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; NNT","url":"https://www.omim.org/entry/607878"},{"mim_id":"202200","title":"GLUCOCORTICOID DEFICIENCY 1; GCCD1","url":"https://www.omim.org/entry/202200"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":223.6},{"tissue":"tongue","ntpm":358.8}],"url":"https://www.proteinatlas.org/search/NNT"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q13423","domains":[{"cath_id":"3.40.50.720","chopping":"51-179_382-433","consensus_level":"high","plddt":92.9956,"start":51,"end":433},{"cath_id":"3.40.50.720","chopping":"195-374","consensus_level":"high","plddt":91.4302,"start":195,"end":374},{"cath_id":"-","chopping":"497-587_595-888","consensus_level":"medium","plddt":95.6443,"start":497,"end":888},{"cath_id":"3.40.50.1220","chopping":"909-1084","consensus_level":"high","plddt":94.1997,"start":909,"end":1084}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13423","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13423-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13423-F1-predicted_aligned_error_v6.png","plddt_mean":90.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NNT","jax_strain_url":"https://www.jax.org/strain/search?query=NNT"},"sequence":{"accession":"Q13423","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13423.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13423/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13423"}},"corpus_meta":[{"pmid":"22634753","id":"PMC_22634753","title":"Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22634753","citation_count":180,"is_preprint":false},{"pmid":"20057372","id":"PMC_20057372","title":"Diet-induced obesity in two C57BL/6 substrains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt) gene.","date":"2010","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20057372","citation_count":148,"is_preprint":false},{"pmid":"23504317","id":"PMC_23504317","title":"Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23504317","citation_count":106,"is_preprint":false},{"pmid":"37244254","id":"PMC_37244254","title":"IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37244254","citation_count":103,"is_preprint":false},{"pmid":"28478381","id":"PMC_28478381","title":"Nicotinamide nucleotide transhydrogenase (NNT) deficiency dysregulates mitochondrial retrograde signaling and impedes proliferation.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28478381","citation_count":67,"is_preprint":false},{"pmid":"24722990","id":"PMC_24722990","title":"Nicotinamide nucleotide transhydrogenase (Nnt) links the substrate requirement in brain mitochondria for hydrogen peroxide removal to the thioredoxin/peroxiredoxin (Trx/Prx) system.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24722990","citation_count":67,"is_preprint":false},{"pmid":"27129361","id":"PMC_27129361","title":"NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.","date":"2016","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27129361","citation_count":61,"is_preprint":false},{"pmid":"29710510","id":"PMC_29710510","title":"Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29710510","citation_count":56,"is_preprint":false},{"pmid":"19906813","id":"PMC_19906813","title":"The deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance.","date":"2009","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19906813","citation_count":56,"is_preprint":false},{"pmid":"34233163","id":"PMC_34233163","title":"NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/34233163","citation_count":55,"is_preprint":false},{"pmid":"30070323","id":"PMC_30070323","title":"LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.","date":"2018","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30070323","citation_count":54,"is_preprint":false},{"pmid":"22593545","id":"PMC_22593545","title":"Nicotinamide nucleotide transhydrogenase (NNT) acts as a novel modulator of macrophage inflammatory responses.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/22593545","citation_count":54,"is_preprint":false},{"pmid":"28628975","id":"PMC_28628975","title":"Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28628975","citation_count":54,"is_preprint":false},{"pmid":"37244051","id":"PMC_37244051","title":"LncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision.","date":"2023","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/37244051","citation_count":53,"is_preprint":false},{"pmid":"27966450","id":"PMC_27966450","title":"Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27966450","citation_count":52,"is_preprint":false},{"pmid":"26025024","id":"PMC_26025024","title":"Loss of Function Mutations in NNT Are Associated With Left Ventricular Noncompaction.","date":"2015","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26025024","citation_count":48,"is_preprint":false},{"pmid":"32763515","id":"PMC_32763515","title":"Nicotinamide nucleotide transhydrogenase (NNT) regulates mitochondrial ROS and endothelial dysfunction in response to angiotensin II.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32763515","citation_count":46,"is_preprint":false},{"pmid":"29046340","id":"PMC_29046340","title":"NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice.","date":"2017","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29046340","citation_count":46,"is_preprint":false},{"pmid":"29857296","id":"PMC_29857296","title":"LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29857296","citation_count":45,"is_preprint":false},{"pmid":"29179477","id":"PMC_29179477","title":"Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29179477","citation_count":44,"is_preprint":false},{"pmid":"30006956","id":"PMC_30006956","title":"Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30006956","citation_count":44,"is_preprint":false},{"pmid":"34845193","id":"PMC_34845193","title":"CircRNA circ-NNT mediates myocardial ischemia/reperfusion injury through activating pyroptosis by sponging miR-33a-5p and regulating USP46 expression.","date":"2021","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34845193","citation_count":42,"is_preprint":false},{"pmid":"28580284","id":"PMC_28580284","title":"NNT reverse mode of operation mediates glucose control of mitochondrial NADPH and glutathione redox state in mouse pancreatic β-cells.","date":"2017","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28580284","citation_count":42,"is_preprint":false},{"pmid":"32489326","id":"PMC_32489326","title":"LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32489326","citation_count":37,"is_preprint":false},{"pmid":"33479472","id":"PMC_33479472","title":"The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33479472","citation_count":37,"is_preprint":false},{"pmid":"32213617","id":"PMC_32213617","title":"Mylk3 null C57BL/6N mice develop cardiomyopathy, whereas Nnt null C57BL/6J mice do not.","date":"2020","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/32213617","citation_count":35,"is_preprint":false},{"pmid":"31923353","id":"PMC_31923353","title":"LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31923353","citation_count":33,"is_preprint":false},{"pmid":"34132374","id":"PMC_34132374","title":"Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34132374","citation_count":33,"is_preprint":false},{"pmid":"32420808","id":"PMC_32420808","title":"LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/32420808","citation_count":32,"is_preprint":false},{"pmid":"32768929","id":"PMC_32768929","title":"Long non-coding RNA NNT-AS1 regulates proliferation, apoptosis, inflammation and airway remodeling of chronic obstructive pulmonary disease via targeting miR-582-5p/FBXO11 axis.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32768929","citation_count":30,"is_preprint":false},{"pmid":"30489194","id":"PMC_30489194","title":"Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.","date":"2018","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30489194","citation_count":30,"is_preprint":false},{"pmid":"32514270","id":"PMC_32514270","title":"LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.","date":"2020","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32514270","citation_count":27,"is_preprint":false},{"pmid":"15450249","id":"PMC_15450249","title":"Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3)/cardiotrophin-like cytokine (CLC)--a novel gp130 cytokine with pleiotropic functions.","date":"2004","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15450249","citation_count":27,"is_preprint":false},{"pmid":"19161594","id":"PMC_19161594","title":"Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt.","date":"2009","source":"PathoGenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19161594","citation_count":27,"is_preprint":false},{"pmid":"21882037","id":"PMC_21882037","title":"Mammalian NADH:ubiquinone oxidoreductase (Complex I) and nicotinamide nucleotide transhydrogenase (Nnt) together regulate the mitochondrial production of H₂O₂--implications for their role in disease, especially cancer.","date":"2011","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/21882037","citation_count":27,"is_preprint":false},{"pmid":"36336710","id":"PMC_36336710","title":"CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy.","date":"2022","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36336710","citation_count":26,"is_preprint":false},{"pmid":"30324628","id":"PMC_30324628","title":"Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30324628","citation_count":24,"is_preprint":false},{"pmid":"31957837","id":"PMC_31957837","title":"LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31957837","citation_count":23,"is_preprint":false},{"pmid":"29805655","id":"PMC_29805655","title":"Long non-coding RNA NNT-AS1 contributes to cell proliferation, metastasis and apoptosis in human ovarian cancer.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29805655","citation_count":23,"is_preprint":false},{"pmid":"35119362","id":"PMC_35119362","title":"Widespread discrepancy in Nnt genotypes and genetic backgrounds complicates granzyme A and other knockout mouse studies.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35119362","citation_count":23,"is_preprint":false},{"pmid":"38521881","id":"PMC_38521881","title":"NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38521881","citation_count":23,"is_preprint":false},{"pmid":"30823587","id":"PMC_30823587","title":"Saturated Fatty Acid Activates T Cell Inflammation Through a Nicotinamide Nucleotide Transhydrogenase (NNT)-Dependent Mechanism.","date":"2019","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30823587","citation_count":23,"is_preprint":false},{"pmid":"32431515","id":"PMC_32431515","title":"Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32431515","citation_count":23,"is_preprint":false},{"pmid":"33463050","id":"PMC_33463050","title":"NNT-induced tumor cell \"slimming\" reverses the pro-carcinogenesis effect of HIF2a in tumors.","date":"2021","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33463050","citation_count":22,"is_preprint":false},{"pmid":"33426064","id":"PMC_33426064","title":"Overexpression of NNT-AS1 Activates TGF-β Signaling to Decrease Tumor CD4 Lymphocyte Infiltration in Hepatocellular Carcinoma.","date":"2020","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/33426064","citation_count":22,"is_preprint":false},{"pmid":"29186589","id":"PMC_29186589","title":"Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons.","date":"2018","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29186589","citation_count":22,"is_preprint":false},{"pmid":"26548497","id":"PMC_26548497","title":"A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD).","date":"2015","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26548497","citation_count":20,"is_preprint":false},{"pmid":"32019904","id":"PMC_32019904","title":"Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32019904","citation_count":19,"is_preprint":false},{"pmid":"31616187","id":"PMC_31616187","title":"Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma.","date":"2019","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/31616187","citation_count":19,"is_preprint":false},{"pmid":"25806335","id":"PMC_25806335","title":"A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumors.","date":"2014","source":"Translational lung cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25806335","citation_count":19,"is_preprint":false},{"pmid":"31782983","id":"PMC_31782983","title":"NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway.","date":"2019","source":"Neurourology and urodynamics","url":"https://pubmed.ncbi.nlm.nih.gov/31782983","citation_count":18,"is_preprint":false},{"pmid":"33113895","id":"PMC_33113895","title":"The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33113895","citation_count":17,"is_preprint":false},{"pmid":"32468065","id":"PMC_32468065","title":"Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32468065","citation_count":17,"is_preprint":false},{"pmid":"40340422","id":"PMC_40340422","title":"Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF.","date":"2025","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/40340422","citation_count":16,"is_preprint":false},{"pmid":"27459240","id":"PMC_27459240","title":"Three-Dimensional Model of Human Nicotinamide Nucleotide Transhydrogenase (NNT) and Sequence-Structure Analysis of its Disease-Causing Variations.","date":"2016","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/27459240","citation_count":16,"is_preprint":false},{"pmid":"25459914","id":"PMC_25459914","title":"NNT pseudoexon activation as a novel mechanism for disease in two siblings with familial glucocorticoid deficiency.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25459914","citation_count":15,"is_preprint":false},{"pmid":"37659467","id":"PMC_37659467","title":"Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification.","date":"2023","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/37659467","citation_count":14,"is_preprint":false},{"pmid":"34198873","id":"PMC_34198873","title":"Loss of Nnt Increases Expression of Oxidative Phosphorylation Complexes in C57BL/6J Hearts.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34198873","citation_count":13,"is_preprint":false},{"pmid":"31848324","id":"PMC_31848324","title":"Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31848324","citation_count":13,"is_preprint":false},{"pmid":"32982585","id":"PMC_32982585","title":"NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32982585","citation_count":12,"is_preprint":false},{"pmid":"31632521","id":"PMC_31632521","title":"High expression of long non-coding RNA NNT-AS1 facilitates progression of cholangiocarcinoma through promoting epithelial-mesenchymal transition.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31632521","citation_count":12,"is_preprint":false},{"pmid":"34643163","id":"PMC_34643163","title":"The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34643163","citation_count":12,"is_preprint":false},{"pmid":"35477026","id":"PMC_35477026","title":"Circ_NNT suppresses the apoptosis and inflammation in glucose-induced human retinal pigment epithelium by regulating miR-320b/TIMP3 axis in diabetic retinopathy.","date":"2022","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/35477026","citation_count":12,"is_preprint":false},{"pmid":"34043997","id":"PMC_34043997","title":"NADPH supply and the contribution of NAD(P)+ transhydrogenase (NNT) to H2O2 balance in skeletal muscle mitochondria.","date":"2021","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/34043997","citation_count":12,"is_preprint":false},{"pmid":"39277608","id":"PMC_39277608","title":"MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39277608","citation_count":11,"is_preprint":false},{"pmid":"36270987","id":"PMC_36270987","title":"Antisense lncRNA NNT-AS1 promoted esophageal squamous cell carcinoma progression by regulating its sense gene NNT expression.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36270987","citation_count":11,"is_preprint":false},{"pmid":"14605001","id":"PMC_14605001","title":"Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extracellular-signal-regulated kinase1/2 pathways.","date":"2003","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14605001","citation_count":11,"is_preprint":false},{"pmid":"16399499","id":"PMC_16399499","title":"The mitochondria and insulin release: Nnt just a passing relationship.","date":"2006","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16399499","citation_count":11,"is_preprint":false},{"pmid":"34149178","id":"PMC_34149178","title":"LncRNA-NNT-AS1 contributes to the progression of glioma by miR-582-5p/EZH2 axis.","date":"2021","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34149178","citation_count":10,"is_preprint":false},{"pmid":"34742256","id":"PMC_34742256","title":"LncRNA NNT-AS1 regulates proliferation, ECM accumulation and inflammation of human mesangial cells induced by high glucose through miR-214-5p/smad4.","date":"2021","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/34742256","citation_count":9,"is_preprint":false},{"pmid":"33246940","id":"PMC_33246940","title":"The energetic cost of NNT-dependent ROS removal.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33246940","citation_count":8,"is_preprint":false},{"pmid":"35627102","id":"PMC_35627102","title":"Long-Term Follow-Up of Three Family Members with a Novel NNT Pathogenic Variant Causing Primary Adrenal Insufficiency.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35627102","citation_count":8,"is_preprint":false},{"pmid":"32187573","id":"PMC_32187573","title":"Enhanced expression of nicotinamide nucleotide transhydrogenase (NNT) and its role in a human T cell line continuously exposed to asbestos.","date":"2020","source":"Environment international","url":"https://pubmed.ncbi.nlm.nih.gov/32187573","citation_count":8,"is_preprint":false},{"pmid":"32629517","id":"PMC_32629517","title":"Nicotinamide Nucleotide Transhydrogenase (Nnt) is Related to Obesity in Mice.","date":"2020","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/32629517","citation_count":7,"is_preprint":false},{"pmid":"35715447","id":"PMC_35715447","title":"Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35715447","citation_count":7,"is_preprint":false},{"pmid":"33478087","id":"PMC_33478087","title":"Cellular Redox State Acts as Switch to Determine the Direction of NNT-Catalyzed Reaction in Cystic Fibrosis Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33478087","citation_count":7,"is_preprint":false},{"pmid":"37352919","id":"PMC_37352919","title":"A novel mutation in the NNT gene causing familial glucocorticoid deficiency, with a literature review.","date":"2023","source":"Annales d'endocrinologie","url":"https://pubmed.ncbi.nlm.nih.gov/37352919","citation_count":6,"is_preprint":false},{"pmid":"32691576","id":"PMC_32691576","title":"Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression.","date":"2020","source":"Journal of biological regulators and homeostatic agents","url":"https://pubmed.ncbi.nlm.nih.gov/32691576","citation_count":6,"is_preprint":false},{"pmid":"38795789","id":"PMC_38795789","title":"Aging-dependent mitochondrial bioenergetic impairment in the skeletal muscle of NNT-deficient mice.","date":"2024","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/38795789","citation_count":5,"is_preprint":false},{"pmid":"34976175","id":"PMC_34976175","title":"Long non-coding RNA NNT-AS1 positively regulates NPM1 expression to affect the proliferation of estrogen-mediated endometrial carcinoma by interacting.","date":"2022","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34976175","citation_count":5,"is_preprint":false},{"pmid":"39978699","id":"PMC_39978699","title":"PARP14 inhibits microglial activation via NNT to alleviate depressive-like behaviors in mice.","date":"2025","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/39978699","citation_count":4,"is_preprint":false},{"pmid":"38261461","id":"PMC_38261461","title":"Lack of NAD(P)+ transhydrogenase activity in patients with primary adrenal insufficiency due to NNT variants.","date":"2024","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/38261461","citation_count":4,"is_preprint":false},{"pmid":"32294154","id":"PMC_32294154","title":"NNT in NSCLC: No need to worry?","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32294154","citation_count":4,"is_preprint":false},{"pmid":"37924851","id":"PMC_37924851","title":"Ubiquitin-specific peptidase 47 (USP47) regulates cutaneous oxidative injury through nicotinamide nucleotide transhydrogenase (NNT).","date":"2023","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37924851","citation_count":3,"is_preprint":false},{"pmid":"40709434","id":"PMC_40709434","title":"Gain-of-function variant in NNT causes premature diffuse familial sebaceous hyperplasia.","date":"2025","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/40709434","citation_count":2,"is_preprint":false},{"pmid":"39827160","id":"PMC_39827160","title":"ApoM maintains cellular homeostasis between mitophagy and apoptosis by affecting the stability of Nnt mRNA through the Zic3-ApoM-Elavl2-Nnt axis during neural tube closure.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39827160","citation_count":2,"is_preprint":false},{"pmid":"39481390","id":"PMC_39481390","title":"Influence of Mitochondrial NAD(P) +  Transhydrogenase (NNT) on Hypothalamic Inflammation and Metabolic Dysfunction Induced by a High-Fat Diet in Mice.","date":"2024","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/39481390","citation_count":2,"is_preprint":false},{"pmid":"36918776","id":"PMC_36918776","title":"Testicular impairment in Primary Adrenal Insufficiency caused by Nicotinamide Nucleotide Transhydrogenase (NNT) deficiency - a case report: implication of oxidative stress and importance of fertility preservation.","date":"2023","source":"Basic and clinical andrology","url":"https://pubmed.ncbi.nlm.nih.gov/36918776","citation_count":2,"is_preprint":false},{"pmid":"38014031","id":"PMC_38014031","title":"MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38014031","citation_count":1,"is_preprint":false},{"pmid":"40463946","id":"PMC_40463946","title":"NNT-AS1, A Long Non-coding RNA with Therapeutic Promise in Mycoplasma Pneumoniae Pneumonia via the Mir-410-3p/TMEM14A/Wnt/ΒCatenin Signalling Pathway.","date":"2025","source":"Iranian journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/40463946","citation_count":1,"is_preprint":false},{"pmid":"9717855","id":"PMC_9717855","title":"Will angiotensin converting enzyme genotype, receptor mutation identification, and other miracles of molecular biology permit reduction of NNT?","date":"1998","source":"American journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/9717855","citation_count":1,"is_preprint":false},{"pmid":"38367989","id":"PMC_38367989","title":"Follow up of a rare case of adrenal insufficiency due to NNT mutation.","date":"2024","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/38367989","citation_count":1,"is_preprint":false},{"pmid":"39917159","id":"PMC_39917159","title":"Familial Glucocorticoid Deficiency Type 4 Caused by a Novel Mutation in the Nicotinamide Nucleotide Transhydrogenase (NNT) Gene: A Clinical Report of Two Siblings.","date":"2025","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/39917159","citation_count":1,"is_preprint":false},{"pmid":"41274037","id":"PMC_41274037","title":"NNT deficiency alters cardiac structure and function without impairing mitochondrial bioenergetics in aged mice.","date":"2025","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/41274037","citation_count":0,"is_preprint":false},{"pmid":"42106800","id":"PMC_42106800","title":"Expression of long non-coding RNA NNT-AS1 in children with severe pneumonia and its effect on lipopolysaccharide-induced human embryonic lung fibroblast injury.","date":"2026","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/42106800","citation_count":0,"is_preprint":false},{"pmid":"41354204","id":"PMC_41354204","title":"NNT inhibits microglial activation via mitochondrial oxidative stress in spinal cord injury.","date":"2025","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/41354204","citation_count":0,"is_preprint":false},{"pmid":"41541237","id":"PMC_41541237","title":"Functional mechanism and clinical implications of lncRNA NNT-AS1 in delayed fracture healing.","date":"2026","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/41541237","citation_count":0,"is_preprint":false},{"pmid":"21602486","id":"PMC_21602486","title":"A high-throughput assay for modulators of NNT activity in permeabilized yeast cells.","date":"2011","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/21602486","citation_count":0,"is_preprint":false},{"pmid":"42233473","id":"PMC_42233473","title":"Sevoflurane pre-treatment attenuates myocardial cell ferroptosis caused by hypoxia and reoxygenation via regulating lncRNA NNT-AS1.","date":"2026","source":"Toxicology mechanisms and methods","url":"https://pubmed.ncbi.nlm.nih.gov/42233473","citation_count":0,"is_preprint":false},{"pmid":"26167508","id":"PMC_26167508","title":"A Mutagenesis Assay for Reporter Gene Screening Using Partially Degenerate Oligonucleotides of the Tandems NNT and NNC.","date":"2015","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/26167508","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54126,"output_tokens":7542,"usd":0.137754,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17055,"output_tokens":4669,"usd":0.101,"stage2_stop_reason":"end_turn"},"total_usd":0.238754,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss-of-function mutations in NNT (nicotinamide nucleotide transhydrogenase) cause familial glucocorticoid deficiency; NNT knockdown in a human adrenocortical cell line impaired redox potential and increased reactive oxygen species (ROS) levels, and Nnt-deficient mice showed higher adrenocortical cell apoptosis and impaired glucocorticoid production, establishing NNT's role in ROS detoxification in adrenal steroidogenesis.\",\n      \"method\": \"Targeted exome sequencing of FGD patients; NNT knockdown in human adrenocortical cell line with ROS/redox assays; mouse Nnt loss-of-function model with histology and hormone measurements\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal human genetics + cell-line KD with redox readout + mouse KO with cellular phenotype, replicated across multiple labs subsequently\",\n      \"pmids\": [\"22634753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NNT, as a mitochondrial NADH-to-NADPH reducing-equivalent transfer enzyme, coordinates reductive carboxylation and glucose catabolism in the TCA cycle: NNT knockdown inhibits glutamine contribution to the TCA cycle and reductive carboxylation by IDH1/IDH2, while activating glucose oxidation; NNT overexpression stimulates glutamine oxidation and reductive carboxylation and inhibits glucose catabolism, effects correlated with changes in NAD(P)H/NAD(P)+ ratios.\",\n      \"method\": \"Stable isotope tracer metabolic flux analysis; NNT knockdown and overexpression in SkMel5 melanoma and 786-O renal carcinoma cells; biochemical NADPH/NADP+ measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isotope tracing plus gain- and loss-of-function in two independent cell lines with cofactor ratio measurements\",\n      \"pmids\": [\"23504317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NNT links mitochondrial respiration to H2O2 detoxification in brain mitochondria via the thioredoxin/peroxiredoxin system: pharmacological inhibition of Nnt in isolated brain mitochondria reduced H2O2 consumption only in the presence of respiration substrates; Nnt inhibition or lentiviral knockdown in N27 dopaminergic cells decreased H2O2 catabolism, reduced NADPH, increased oxidized mitochondrial Prx, and sensitized cells to paraquat-induced death.\",\n      \"method\": \"Pharmacological inhibition of NNT in isolated brain and liver mitochondria; lentiviral Nnt knockdown in N27 dopaminergic cells; H2O2 consumption assays; NADPH/NADP+ measurements; Prx redox state assays; cell viability assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (isolated organelle assay, pharmacological inhibition, lentiviral KD, redox reporters) in single rigorous study\",\n      \"pmids\": [\"24722990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In pancreatic β-cells, NNT operates primarily in reverse mode (consuming NADPH to support NADH) at non-stimulating glucose concentrations; glucose stimulation reduces NADPH consumption by NNT reverse mode, accounting for the glucose-induced rise in NADPH/NADP+ and decrease in mitochondrial glutathione oxidation. Loss of NNT in C57BL/6J islets did not alter Ca2+ influx or mitochondrial events but markedly reduced both phases of glucose-stimulated insulin secretion (GSIS) by altering Ca2+-induced exocytosis and its metabolic amplification.\",\n      \"method\": \"Comparison of NNT-null C57BL/6J vs. wild-type C57BL/6N islets; adenoviral NNT re-expression in J-islets; glutaredoxin 1-fused roGFP2 mitochondrial/cytosolic glutathione probes; biochemical NADPH/NADH measurements; dynamic insulin secretion assays; Ca2+ imaging\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genetically defined NNT-null vs. wild-type islets plus adenoviral rescue, multiple orthogonal reporters including live redox sensors\",\n      \"pmids\": [\"28580284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NNT is essential for homeostasis of NADH and NADPH pools in cancer cells; NNT knockdown in SK-Hep1 cells decreased NAD+ and NADPH, increased α-ketoglutarate/succinate ratio leading to reduced HIF-1α levels and HIF-1α-regulated gene expression, reduced HDAC1 activity, increased p53 acetylation, increased dependence on oxidative phosphorylation, and impaired proliferation and tumorigenicity.\",\n      \"method\": \"NNT knockdown in SK-Hep1 cells; stable isotope tracer metabolic flux analysis; measurement of HIF-1α, HDAC1 activity, p53 acetylation; proliferation and tumorigenicity assays\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isotope tracing plus multiple pathway readouts in single lab, single cell line\",\n      \"pmids\": [\"28478381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Transcriptomic profiling of adrenals from Nnt wild-type (C57BL/6N), Nnt-null (C57BL/6J), and BAC-transgenic Nnt-overexpressing mice showed that both under- and overexpression of NNT reduces adrenal steroidogenic output, correlating with decreased expression of mitochondrial antioxidant enzymes (Prdx3, Txnrd2) and the steroidogenic enzyme Cyp11a1, establishing NNT as a central regulator of adrenal redox homeostasis and steroidogenesis.\",\n      \"method\": \"RNA-seq on adrenals from three isogenic mouse models; corticosterone measurements; pathway enrichment analysis\",\n      \"journal\": \"The Journal of endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — three genetic models with transcriptomic and hormone output, single lab\",\n      \"pmids\": [\"29046340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NNT regulates macrophage inflammatory responses: NNT overexpression in a macrophage cell line decreased ROS and nitric oxide upon LPS activation, impaired MAPK signaling pathway activation, reduced proinflammatory cytokine secretion, and impaired clearance of intracellular bacteria; conversely, C57BL/6J mice lacking functional Nnt showed greater macrophage ROS generation and stronger inflammatory response to Streptococcus pneumoniae infection.\",\n      \"method\": \"NNT overexpression in macrophage cell line; ROS and NO measurements; MAPK activation assays; cytokine secretion assays; intracellular bacterial clearance; in vivo infection model with Nnt-null C57BL/6J mice\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function in vitro plus in vivo Nnt-null mouse infection model, multiple orthogonal readouts, single lab\",\n      \"pmids\": [\"22593545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NNT controls cellular redox state and skin pigmentation via a UVB- and MITF-independent mechanism: NNT inhibition causes redox changes that increase tyrosinase protein levels (by reducing tyrosinase degradation), promote melanosome maturation, and elevate eumelanin/pigmentation; topical NNT inhibitors darkened human skin ex vivo, and mice with decreased NNT function and zebrafish with genetic NNT modification displayed increased melanocytic pigmentation.\",\n      \"method\": \"Small-molecule NNT inhibitor topical application on human skin; NNT mouse models; CRISPR genetic modification of NNT in zebrafish; tyrosinase stability assays; melanosome maturation analysis; eumelanin quantification\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal model systems (human skin, mouse in vivo, zebrafish genetic), mechanistic link to tyrosinase degradation established\",\n      \"pmids\": [\"34233163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss-of-function mutations in NNT are associated with left ventricular noncompaction (LVNC); suppression of nnt in zebrafish caused early ventricular malformation and contractility defects likely driven by altered cardiomyocyte proliferation; in vivo complementation with mutant human NNT failed to rescue nnt morpholino-induced heart dysfunction, indicating haploinsufficiency.\",\n      \"method\": \"Whole exome sequencing; zebrafish nnt morpholino knockdown with cardiac phenotyping; in vivo complementation with human NNT constructs\",\n      \"journal\": \"Circulation. Cardiovascular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — zebrafish in vivo model with complementation assay, single lab\",\n      \"pmids\": [\"26025024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NNT critically regulates mitochondrial redox balance and endothelial function in response to angiotensin II: NNT knockdown in human aortic endothelial cells elevated mitochondrial ROS, impaired glutathione peroxidase and reductase activities, reduced NADPH/NADP+ ratio, disrupted mitochondrial membrane potential, impaired ATP production, and augmented eNOS phosphorylation at Ser1177 without increasing eNOS activity or NO production.\",\n      \"method\": \"NNT shRNA knockdown in human aortic endothelial cells; mitochondrial ROS measurement; glutathione enzyme activity assays; NADPH/NADP+ ratio; mitochondrial membrane potential; ATP production; eNOS phosphorylation and activity assays\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical readouts in human primary cells, single lab\",\n      \"pmids\": [\"32763515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"IL-1β stimulation causes acetylation of NNT at lysine K1042 (NNT K1042ac) via PCAF (p300/CBP-associated factor), which translocates to mitochondria upon IL-1β stimulation; K1042 acetylation enhances NNT enzymatic activity by increasing NNT's binding affinity for NADP+, boosting NADPH production, which sustains iron-sulfur cluster maintenance and protects tumor cells from ferroptosis and immune evasion.\",\n      \"method\": \"Co-IP and mitochondrial fractionation for PCAF translocation; acetylation site mapping; NADP+ binding affinity assays; site-directed mutagenesis of K1042; iron-sulfur cluster assays; ferroptosis assays; PD-1 blockade combination studies\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — post-translational modification identified with writer (PCAF), mutagenesis of modification site, enzymatic activity assay, multiple functional readouts\",\n      \"pmids\": [\"37244254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A 3D structural model of human NNT based on bacterial transhydrogenase crystal structures identified key functional residues including the NAD binding site, the proton canal, and the dimerization interface; the flexible linker between domains II and III and a salt bridge between Arg882 and Asp830 are critical for domain III conformational changes associated with NNT's functional cycle; disease-causing FGD and LVNC missense variants map to these functionally critical regions.\",\n      \"method\": \"Homology modeling using bacterial transhydrogenase experimental structures; sequence-structure analysis; mapping of disease variants onto structural model\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational structural model only, no direct experimental structural validation\",\n      \"pmids\": [\"27459240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NNT expression is transcriptionally regulated by MITF (microphthalmia-associated transcription factor) through direct binding to canonical E-BOX sequences proximal to the NNT promoter; MITF-driven NNT expression contributes to a global antioxidant program reducing cytosolic and mitochondrial ROS in melanoma cells.\",\n      \"method\": \"ChIP for MITF binding to NNT promoter E-BOX; ROS measurements in MITF-manipulated melanoma cells; NNT functional assays; zebrafish melanoma model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct transcription factor binding plus functional ROS readouts, peer-reviewed replication of preprint\",\n      \"pmids\": [\"39277608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In skeletal muscle mitochondria (SMM), NNT supplies NADPH capable of supporting up to 600 pmol/mg/min of H2O2 removal; however, NNT-null (Nnt-/-) SMM maintained H2O2 removal at wild-type levels due to compensatory ~70% elevation in total activities of concurrent NADP+-reducing enzymes (IDH2, malic enzymes, glutamate dehydrogenase).\",\n      \"method\": \"Comparison of SMM from Nnt+/+ and Nnt-/- mice; H2O2 removal assays in intact and detergent-solubilized mitochondria; enzymatic activity assays for IDH2, malic enzymes, glutamate dehydrogenase; oxygen consumption measurements\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetically defined mouse model with multiple in vitro organelle assays, single lab\",\n      \"pmids\": [\"34043997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NNT activity direction is determined by cellular redox state: in cystic fibrosis (CF) cells, NNT protein is elevated ~70% but NNT activity is ~30% lower than wild-type; the oxidized cellular redox state combined with low mitochondrial membrane potential drives NNT to operate in reverse mode (consuming NADPH to produce NADH), reducing its antioxidant function.\",\n      \"method\": \"Spectrophotometric NNT activity assays; western blotting for NNT protein; NADPH and NADH level measurements; mitochondrial ROS quantification; mitochondrial membrane potential measurements in CF vs. wild-type cells\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays in defined disease vs. control cells, single lab\",\n      \"pmids\": [\"33478087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Human NNT was functionally expressed in Saccharomyces cerevisiae for the first time; mitochondria isolated from NNT-expressing yeast showed six-fold higher transhydrogenase activity than wild-type yeast mitochondria and partially uncoupled respiration, confirming NNT acts as a redox-driven proton pump; a fluorimetric assay for NNT activity in permeabilized yeast was developed and validated for pharmacological compound screening.\",\n      \"method\": \"Heterologous expression of human NNT cDNA in yeast; transhydrogenase activity assay in isolated yeast mitochondria; respiratory measurements; fluorimetric assay development and pharmacological compound library screen\",\n      \"journal\": \"Journal of biomolecular screening\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — reconstitution of human NNT in yeast with enzymatic activity confirmation, single study, single lab\",\n      \"pmids\": [\"21602486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NNT is silenced by DNA hypermethylation in cisplatin-resistant NSCLC cells; NNT overexpression reduced cisplatin resistance primarily by inhibiting protective autophagy through decreasing NAD+ levels and thereby inactivating SIRT1 (not through direct NADPH/ROS effects); targeted demethylation of the NNT CpG island via CRISPR/dCas9-Tet1 restored NNT expression and reduced autophagy and cisplatin resistance.\",\n      \"method\": \"DNA methylation analysis; NNT overexpression in A549/DDP cells; autophagy assays; NAD+ level measurements; SIRT1 activity assays; NAD+ precursor rescue experiments; CRISPR/dCas9-Tet1 targeted demethylation\",\n      \"journal\": \"Archives of toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway (NNT→NAD+→SIRT1→autophagy) defined with multiple orthogonal methods and CRISPR epigenetic rescue, single lab\",\n      \"pmids\": [\"36336710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP47 (ubiquitin-specific protease 47) regulates NNT protein stability through direct deubiquitination: proteomic analysis of Usp47-/- mouse skin showed NNT downregulation; NNT knockdown in irradiated HaCaT cells elevated mitochondrial ROS and mitochondrial membrane potential and impaired energy production, establishing NNT as a downstream effector of USP47 in cutaneous oxidative stress responses.\",\n      \"method\": \"Usp47-/- mouse skin models (radiation and imiquimod); proteomic analysis; NNT knockdown in HaCaT cells; mitochondrial ROS assays; mitochondrial membrane potential assays; ATP production measurements\",\n      \"journal\": \"Toxicology and applied pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro complementary models identifying USP47 as NNT-regulatory deubiquitinase, single lab\",\n      \"pmids\": [\"37924851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PARP14 positively regulates NNT expression in microglia; loss of NNT caused ROS accumulation and microglial inflammation, which was suppressed by NNT overexpression or by the ROS inhibitor N-Acetylcysteine; PARP14-mediated NNT upregulation suppresses microglial activation and alleviates depressive-like behavior in CUS mice.\",\n      \"method\": \"PARP14 knockdown/overexpression in hippocampus of CUS mice; microglial-targeted PARP14 overexpression; NNT overexpression rescue; ROS measurements; NAC treatment; depressive behavioral testing\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (PARP14→NNT→ROS→inflammation) established with in vivo rescue and ROS inhibitor confirmation, single lab\",\n      \"pmids\": [\"39978699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NNT promotes diastolic dysfunction in cardiometabolic HFpEF: isogenic Nnt+/+ mice subjected to HFD+L-NAME developed significantly worse diastolic dysfunction (elevated E/e', E/A, diastolic stiffness, myocardial fibrosis) compared to Nnt-/- mice; Nnt+/+ mice showed 40% reduction in NAD+ and 38.8% reduction in GSH:GSSG ratio after HFD+L-NAME; single-nucleus ligand-receptor analysis implicated Fgf1 as a putative NNT-dependent mediator of cardiomyocyte-to-fibroblast signaling in fibrosis.\",\n      \"method\": \"Isogenic Nnt+/+ vs. Nnt-/- mouse model in C57BL/6N background; HFD+L-NAME 2-hit HFpEF model; echocardiography; liquid chromatography-mass spectrometry for NAD+/glutathione; histology for fibrosis; single-nucleus transcriptomics and ligand-receptor analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic genetic model with multiple cardiac and metabolic readouts, single lab\",\n      \"pmids\": [\"40340422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Pathogenic NNT variants in patients with primary adrenal insufficiency result in complete absence of NAD(P)+ transhydrogenase activity (<4% of controls) in peripheral blood mononuclear cells, independent of the specific variant; heterozygous carrier parents have approximately half normal NNT activity; pathogenic NNT variants do not impair mitochondrial bioenergetic function (oxygen consumption) in PBMCs.\",\n      \"method\": \"Reverse reaction NNT enzymatic assay in digitonin-permeabilized PBMCs from patients, carriers, and controls; western blotting for NNT protein; RT-qPCR; mitochondrial oxygen consumption; validated in mouse NNT-null PBMC samples\",\n      \"journal\": \"European journal of endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct enzymatic activity assay in patient-derived primary cells validated against mouse model, single lab\",\n      \"pmids\": [\"38261461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A gain-of-function missense variant in NNT (c.2063T>G, p.Leu688Trp) causes premature diffuse familial sebaceous hyperplasia by enhancing NNT antioxidant capacity: patient-derived keratinocytes and NNT-knockdown sebocytes overexpressing mutant NNT showed elevated NADPH/NADP+ ratio, increased glutathione, decreased ROS, and decreased susceptibility to ferroptosis compared to wild-type NNT.\",\n      \"method\": \"Whole-exome sequencing; functional assays in patient-derived keratinocytes; NNT-knockdown SZ95 sebocytes with mutant NNT overexpression; NADPH/NADP+ quantification; glutathione assays; ROS measurements; C11-BODIPY ferroptosis assays; flow cytometry; electron microscopy of mitochondria\",\n      \"journal\": \"The British journal of dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — gain-of-function variant characterized with enzymatic and redox readouts in patient-derived and engineered cells, single lab\",\n      \"pmids\": [\"40709434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NNT deficiency causes age-dependent skeletal muscle bioenergetic impairment: Nnt-/- mice showed decreased respiratory rates in soleus and vastus lateralis muscles at middle and older ages (but not in young mice), increased centralized nuclei in older soleus fibers, and worsened wire-hang performance; soleus, the muscle with highest NNT expression, was most affected by NNT loss during aging.\",\n      \"method\": \"Nnt-/- vs. Nnt+/+ mice across three ages; wire-hang locomotor performance test; mitochondrial respiration in fiber bundles from multiple muscles; histology with centralized nuclei scoring; NNT expression profiling across muscles\",\n      \"journal\": \"Experimental gerontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic genetic model with longitudinal functional and organelle-level measurements, single lab\",\n      \"pmids\": [\"38795789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Saturated fatty acid palmitate decreases NNT expression in PBMCs, reducing NADPH and glutathione and increasing ROS and Th17 proinflammatory cytokines; genetic inhibition of NNT recapitulated these effects; obese subjects had lower NNT and glutathione expression compared to lean subjects, identifying NNT as a palmitate-regulated rheostat of redox balance in immune cells.\",\n      \"method\": \"Palmitate treatment of PBMCs from lean subjects; genetic NNT inhibition in PBMCs; NADPH, glutathione, ROS measurements; cytokine assays; comparison with obese vs. lean subjects\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic NNT manipulation with multiple redox and inflammatory readouts, single lab\",\n      \"pmids\": [\"30823587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NNT downregulation in clear cell renal cell carcinoma is mediated by HIF2α, which enhances miR-455-5p expression via HIF2α-response elements in the miR-455-5p promoter; miR-455-5p in turn suppresses NNT expression by binding to its 3' UTR. Reduced NNT leads to decreased lipid browning-mediated tumor cell 'slimming', promoting tumor progression.\",\n      \"method\": \"HIF2α knockdown followed by NNT expression analysis; ChIP for HIF2α binding to miR-455-5p promoter; luciferase reporter assay confirming miR-455-5p targeting of NNT 3' UTR; cell line and animal models\",\n      \"journal\": \"Clinical and translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus luciferase validation of regulatory axis, single lab\",\n      \"pmids\": [\"33463050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NNT deficiency in aged mice causes cardiac hypertrophy and moderately reduced ejection fraction/fractional shortening, associated with increased mitochondrial H2O2 release under specific conditions; mitochondrial bioenergetic parameters and Ca2+ retention capacity were largely unaffected by Nnt genotype at all ages, indicating NNT protects aging heart through redox balance maintenance without being essential for bioenergetics.\",\n      \"method\": \"Nnt-/- vs. Nnt+/+ mice assessed at 5, 12, and 23 months; echocardiography; mitochondrial H2O2 production assays; mitochondrial respiration; Ca2+ retention capacity assays; cardiac histology\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic longitudinal genetic model with multiple cardiac and mitochondrial readouts, single lab\",\n      \"pmids\": [\"41274037\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NNT (nicotinamide nucleotide transhydrogenase) is an inner mitochondrial membrane proton-translocating enzyme that couples the proton gradient to transfer reducing equivalents from NADH to NADPH (forward mode), thereby maintaining the mitochondrial NADPH pool for ROS detoxification via the thioredoxin/peroxiredoxin and glutathione systems; it can also operate in reverse (consuming NADPH to support NADH) depending on cellular redox state, and its activity is post-translationally enhanced by IL-1β-induced PCAF-mediated acetylation at K1042; NNT is a critical regulator of adrenal steroidogenesis, pancreatic β-cell insulin secretion, macrophage inflammatory responses, skin pigmentation via tyrosinase stability, and cardiomyocyte redox homeostasis, with loss-of-function mutations causing familial glucocorticoid deficiency in humans.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NNT is an inner mitochondrial membrane, redox-driven proton pump that couples the respiratory proton gradient to transfer of reducing equivalents from NADH to NADP+, maintaining the mitochondrial NADPH pool that feeds the thioredoxin/peroxiredoxin and glutathione antioxidant systems [#2, #15]. Heterologous expression of human NNT in yeast confirmed it functions as a transhydrogenase that partially uncouples respiration, and patient-derived cells from primary adrenal insufficiency show that pathogenic variants abolish NAD(P)+ transhydrogenase activity while leaving mitochondrial bioenergetics intact [#15, #20]. The direction of NNT catalysis is set by cellular redox state and membrane potential: in pancreatic \\u03b2-cells and in oxidized, low-potential conditions NNT runs in reverse, consuming NADPH to generate NADH [#3, #14]. By controlling NADPH and NAD(H) pools, NNT governs reductive carboxylation and the balance between glutamine and glucose catabolism in the TCA cycle [#1]. NNT activity is acutely enhanced by IL-1\\u03b2-triggered, PCAF-mediated acetylation at K1042, which raises NADP+ binding affinity to boost NADPH output, sustaining iron-sulfur cluster maintenance and protecting tumor cells from ferroptosis [#10]. Through this redox/ROS-buffering function NNT is a central regulator of adrenal steroidogenesis, where both loss and overexpression reduce steroidogenic output [#0, #5]; of pancreatic \\u03b2-cell glucose-stimulated insulin secretion [#3]; of macrophage and microglial inflammatory responses [#6, #18]; of skin pigmentation via redox-dependent tyrosinase stability [#7]; and of cardiomyocyte and endothelial redox homeostasis [#9, #25]. Loss-of-function NNT mutations cause familial glucocorticoid deficiency [#0], and a gain-of-function variant causes familial sebaceous hyperplasia by enhancing antioxidant capacity [#21]. NNT expression is itself regulated transcriptionally by MITF and post-translationally by the deubiquitinase USP47 [#12, #17].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing whether human NNT is itself a redox-driven proton-pumping transhydrogenase required reconstituting the isolated enzyme, which heterologous yeast expression provided along with a screenable activity assay.\",\n      \"evidence\": \"Heterologous expression of human NNT in S. cerevisiae with transhydrogenase and respiratory assays and a fluorimetric screen\",\n      \"pmids\": [\"21602486\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution experimental structure of human NNT\", \"Directionality control in intact mammalian cells not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linking NNT to human disease defined its physiological role: loss-of-function mutations cause familial glucocorticoid deficiency through failure of ROS detoxification in steroidogenic adrenal cells.\",\n      \"evidence\": \"Exome sequencing of FGD patients, adrenocortical cell-line knockdown with redox/ROS assays, and Nnt-deficient mice\",\n      \"pmids\": [\"22634753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between redox imbalance and the steroidogenic defect not fully resolved\", \"Tissue-selectivity of the adrenal phenotype unexplained\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Whether NNT shapes innate immunity was tested by manipulating it in macrophages, showing NNT dampens ROS-driven inflammatory signaling and bacterial responses.\",\n      \"evidence\": \"NNT overexpression in macrophages plus Nnt-null mouse infection model with ROS, MAPK, and cytokine readouts\",\n      \"pmids\": [\"22593545\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular target downstream of redox change not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"How NNT integrates into central carbon metabolism was clarified: by setting NAD(P)H/NAD(P)+ ratios it coordinates reductive carboxylation versus glucose oxidation in the TCA cycle.\",\n      \"evidence\": \"Stable-isotope flux analysis with NNT loss- and gain-of-function in melanoma and renal carcinoma cells\",\n      \"pmids\": [\"23504317\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of the flux shifts not established\", \"Does not address directional switching of NNT\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The mechanistic basis for NNT's antioxidant function was tied to respiration-dependent NADPH supply feeding the thioredoxin/peroxiredoxin system for H2O2 removal.\",\n      \"evidence\": \"Pharmacological inhibition and knockdown in brain mitochondria and dopaminergic cells with H2O2 consumption and Prx redox readouts\",\n      \"pmids\": [\"24722990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution versus other NADPH sources not quantified here\", \"In vivo neuronal consequence not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolving NNT's catalytic direction in vivo, \\u03b2-cell studies showed it runs in reverse at low glucose and that this redox switching shapes glucose-stimulated insulin secretion.\",\n      \"evidence\": \"NNT-null vs wild-type islets with adenoviral rescue, live glutathione redox probes, and dynamic insulin secretion assays\",\n      \"pmids\": [\"28580284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular sensor coupling NNT directionality to glucose not defined\", \"Exocytosis amplification mechanism incompletely mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"NNT's role in cancer cell fitness was probed, linking its control of NAD+/NADPH to HIF-1\\u03b1 stability, HDAC1/p53 acetylation, and proliferation.\",\n      \"evidence\": \"NNT knockdown in SK-Hep1 cells with flux analysis and multiple pathway readouts\",\n      \"pmids\": [\"28478381\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line\", \"Causal chain from cofactor change to each downstream node not isolated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Adrenal transcriptomics across three isogenic genotypes established NNT as a dose-sensitive regulator, since both under- and overexpression depress steroidogenesis and antioxidant gene expression.\",\n      \"evidence\": \"RNA-seq and corticosterone measurement in Nnt-null, wild-type, and overexpressing mice\",\n      \"pmids\": [\"29046340\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of overexpression toxicity not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NNT was shown to control skin pigmentation through a UVB/MITF-independent redox mechanism that stabilizes tyrosinase and promotes melanosome maturation.\",\n      \"evidence\": \"Small-molecule NNT inhibition on human skin ex vivo plus mouse and zebrafish models with tyrosinase stability and eumelanin assays\",\n      \"pmids\": [\"34233163\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redox species that controls tyrosinase degradation not pinpointed\", \"Degradation machinery involved not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Endothelial studies extended NNT's antioxidant role to vascular biology, showing its loss elevates mitochondrial ROS and disrupts bioenergetics in response to angiotensin II.\",\n      \"evidence\": \"NNT shRNA knockdown in human aortic endothelial cells with redox, membrane potential, ATP, and eNOS assays\",\n      \"pmids\": [\"32763515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"eNOS Ser1177 phosphorylation increase without NO change unexplained\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A regulatory layer was uncovered: IL-1\\u03b2-driven PCAF acetylation of NNT at K1042 enhances NADP+ binding and NADPH output, protecting tumor cells from ferroptosis and immune attack.\",\n      \"evidence\": \"Co-IP/fractionation for PCAF, acetylation site mapping, K1042 mutagenesis, NADP+ binding and ferroptosis assays, PD-1 blockade studies\",\n      \"pmids\": [\"37244254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Deacetylase counteracting K1042ac not identified\", \"Generality beyond the tumor context tested unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"NNT protein stability was shown to be set by deubiquitination, identifying USP47 as a regulator upstream of NNT in cutaneous oxidative stress.\",\n      \"evidence\": \"Usp47-/- mouse skin proteomics plus NNT knockdown in HaCaT cells with mitochondrial ROS and energy assays\",\n      \"pmids\": [\"37924851\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct USP47\\u2013NNT interaction and ubiquitin sites not mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Direct enzymatic assays in patient cells established that pathogenic NNT variants abolish transhydrogenase activity without impairing mitochondrial bioenergetics, refining the disease mechanism.\",\n      \"evidence\": \"Reverse-reaction NNT assay in permeabilized PBMCs from patients, carriers, and controls with oxygen consumption measurements\",\n      \"pmids\": [\"38261461\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not explain tissue specificity of adrenal failure\", \"Bioenergetic readout limited to PBMCs\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A gain-of-function NNT variant defined the opposite end of the dose-response, causing sebaceous hyperplasia by enhancing antioxidant capacity and ferroptosis resistance.\",\n      \"evidence\": \"Exome sequencing and functional assays in patient keratinocytes and mutant-NNT sebocytes with NADPH, glutathione, ROS, and ferroptosis readouts\",\n      \"pmids\": [\"40709434\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the activating effect not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Longitudinal cardiac and muscle models clarified that NNT protects aging tissue through redox balance rather than core bioenergetics, with effects on hypertrophy, diastolic dysfunction, and muscle performance.\",\n      \"evidence\": \"Isogenic Nnt-/- vs Nnt+/+ mice across ages with echocardiography, HFpEF modeling, mitochondrial H2O2 and respiration assays, and single-nucleus transcriptomics\",\n      \"pmids\": [\"41274037\", \"40340422\", \"38795789\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Fgf1 as NNT-dependent cardiomyocyte-fibroblast mediator only correlative\", \"Genetic-background confounds (C57BL/6J Nnt allele) require care in interpretation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NNT directionality is dynamically sensed and switched within intact mammalian tissues, and what governs its dose-sensitive, context-specific phenotypes, remains incompletely defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No experimental high-resolution structure of human NNT\", \"Deacetylase opposing K1042ac unidentified\", \"Mechanistic basis of dose-sensitivity (loss vs overexpression both harmful) unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [2, 13, 15, 20]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 3, 10, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 2, 9, 25]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [10, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PCAF\", \"USP47\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}